drugset / Trial / NCT00444106

Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function

NCT00444106

Phase 4 Completed 265 enrolled Novartis
RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the potential effects of artemether- lumefantrine on the auditory function

Timeline

Start
2007-05
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Artemether Small molecule 20 mg Oral
Comparator Artesunate Small molecule 4 mg/kg Oral
Comparator Artesunate Small molecule 50 mg Oral
Comparator Atovaquone Small molecule 250 mg Oral
Comparator Mefloquine Unknown 25 mg/kg Oral
Comparator Mefloquine Unknown 250 mg Oral
Comparator Proguanil Small molecule 100 mg Oral
Subject lumefantrine Small molecule 120 mg Oral